Symptoms | All patients n = 327 n (%) | Patients without adverse outcome n = 277 n (%) | Patient with adverse outcome n = 50 n (%) | P-value |
---|---|---|---|---|
Respiratory difficulties | 219 (67%) | 180 (65%) | 39 (78%) | 0.07 |
Muscle weaknessa | 84 (26%) | 70 (25%) | 14 (28%) | 0.68 |
Gastrointestinal symptomsb | 60 (18%) | 53 (19%) | 7 (14%) | 0.39 |
Altered mental statusc | 58 (18%) | 43 (15%) | 15 (30%) | 0.01* |
Pain unspecifiedd | 56 (17%) | 45 (16%) | 11 (22%) | 0.32 |
Shivering | 52 (16%) | 49 (18%) | 3 (6%) | 0.04* |
Chest discomfort | 28 (9%) | 26 (9%) | 2 (4%) | 0.21 |
Abdominal pain | 28 (9%) | 23 (8%) | 5 (10%) | 0.69 |